Abstract
Background and study aims In patients taking different regimens of antithrombotic and/or anticoagulant therapy,
endoscopic management of gastrointestinal bleeding represents a major challenge due
to failing endogenous hemostasis. In this retrospective study we report on success
rates with the over-the-scope clip (OTSC) system in upper and lower gastrointestinal
bleeding in this high-risk patient population.
Patients and methods Between February 2011 and June 2014, 75 patients were treated with an OTSC for active
gastrointestinal bleeding. Success rates with the first endoscopic therapy, rebleeding
episodes, their management and the influence of antithrombotic or anticoagulant therapy
were analyzed retrospectively.
Results Application of the OTSC resulted in immediate hemostasis (primary success rate) in
all 75 patients. However, in 34.7 % a rebleeding episode was noted that could be treated
by further endoscopic interventions. Only 3 patients had to be sent to the operating
room because of failure of endoscopic therapy. In the rebleeding group the use of
antiplatelet therapies was higher (73.1 % vs. 48.9 %).
Conclusions Application of the OTSC in GI bleeding results in a high rate of primary hemostasis.
Rebleeding occurs in up to 35 % of patients receiving antithrombotic/anticoagulant
therapy but can be managed successfully with further endoscopic treatments. Patients
in the rebleeding group were more frequently treated with antiplatelet agents. Radiological
or surgical therapy was reserved for a small subgroup not successfully managed by
repeated endoscopic therapies. OTSC application is the treatment of choice in high-risk
patients when conventional clips used as first-line treatment fail.